Use of immersive virtual reality therapy as a part of multimodal approach in modulating pain in patients of burn injury of hands

Use of immersive virtual reality therapy as a part of multimodal approach in modulating pain in patients of burn injury of hands.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035828

Enrollment

Registered

2021-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L98- Other disorders of skin and subcutaneous tissue, not elsewhere classified

Interventions

Intervention1: GROUP VR (IMMERSIVE VIRTUAL REALITY THERAPY): GROUP VR WILL BE ASKED TO WEAR HMD AND PLAY A 3D GAME IN VR FOR 10MINS AND WILL BE ASKED NRS PAIN SCALE RATING FROM 0 TO 10 BEFORE AND AFTE

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of burn injury of hands of 2weeks -12 weeks duration. 2. ASA I and II patients, of age varying from 15years to 60 years. 3. No h/o neurological or cognitive dysfunction. 4. Can perform hands movement without assistance

Exclusion criteria

Exclusion criteria: 1. Patients with amputated limb/phantom limb. 2. H/o susceptibility to motion sickness. 3. History of claustrophobia 4. Patients reported a feeling of anxiety or discomfort while viewing 3D environment. 5. Patients with psychiatric illness and seizure disorders. 6. Burn to face/scalp which prevent use of HMD. 7. Deaf /visually challenged patients 8. Acute infection. 9. Burn > 30% bodysurface surface area

Design outcomes

Primary

Measure	Time frame
EFFECT OF VR ON PAIN INTENSITY IN PATIENTS OF BURN INJURY OF HANDSTimepoint: 4 WEEKS	—

Secondary

Measure	Time frame
To explore the efficacy of virtual reality (VR) therapy on: 1. Requirements of analgesics on weekly basis. 2. Patient satisfaction score. 3. Improvement of quality of life using SF-12 Score. 4. Adverse outcome effects. Timepoint: 4 WEEKS	—

Countries

India

Contacts

Public ContactBALASUBRAMANIYAM C

JNMCH,AMU

hammadusmani2002@gmail.com9897114190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026